S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Perrigo Stock Forecast, Price & News

-0.04 (-0.11%)
(As of 12/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.27 million shs
Average Volume
1.53 million shs
Market Capitalization
$4.79 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

Perrigo logo

About Perrigo

Perrigo Co. Plc provides self-care products and over-the-counter (OTC) health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.


See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Year Founded

Sales & Book Value

Annual Sales
$5.06 billion
Cash Flow
$5.66 per share
Book Value
$38.76 per share


Net Income
$-162.60 million
Pretax Margin




Free Float
Market Cap
$4.79 billion

Company Calendar

Last Earnings
Dividend Payable
Fiscal Year End
Next Earnings (Estimated)

Social Links


Overall MarketRank

3.39 out of 5 stars

Medical Sector

8th out of 1,390 stocks

Pharmaceutical Preparations Industry

1st out of 668 stocks

Analyst Opinion: 3.3Community Rank: 4.5Dividend Strength: 3.3Insider Behavior: 3.3Valuation: 2.5 5 -4 -3 -2 -1 -

Perrigo (NYSE:PRGO) Frequently Asked Questions

Is Perrigo a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Perrigo stock.
View analyst ratings for Perrigo
or view top-rated stocks.

How has Perrigo's stock price been impacted by COVID-19 (Coronavirus)?

Perrigo's stock was trading at $46.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PRGO stock has decreased by 22.3% and is now trading at $35.79.
View which stocks have been most impacted by COVID-19

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022.
View our earnings forecast for Perrigo

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) issued its earnings results on Wednesday, November, 10th. The company reported $0.45 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.65 by $0.20. Perrigo had a positive trailing twelve-month return on equity of 5.88% and a negative net margin of 5.86%. During the same period in the prior year, the business earned $0.93 earnings per share.
View Perrigo's earnings history

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo announced a quarterly dividend on Tuesday, November 2nd. Shareholders of record on Friday, December 3rd will be paid a dividend of $0.24 per share on Tuesday, December 21st. This represents a $0.96 annualized dividend and a yield of 2.68%. The ex-dividend date of this dividend is Thursday, December 2nd.
View Perrigo's dividend history

Is Perrigo a good dividend stock?

Perrigo pays an annual dividend of $0.96 per share and currently has a dividend yield of 2.68%.
View Perrigo's dividend history.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY 2021 earnings guidance on Wednesday, December, 1st. The company provided EPS guidance of $2.000-$2.100 for the period, compared to the Thomson Reuters consensus estimate of $2.460. The company issued revenue guidance of -.

What price target have analysts set for PRGO?

4 brokers have issued 12-month price objectives for Perrigo's stock. Their forecasts range from $45.00 to $63.00. On average, they anticipate Perrigo's share price to reach $52.75 in the next year. This suggests a possible upside of 47.4% from the stock's current price.
View analysts' price targets for Perrigo
or view top-rated stocks among Wall Street analysts.

Who are Perrigo's key executives?

Perrigo's management team includes the following people:
  • Murray S. Kessler, President, Chief Executive Officer & Director
  • Raymond P. Silcock, CFO, Principal Accounting Officer & Executive VP
  • Thomas M. Farrington, Chief Information Officer & Executive VP
  • Grainne Quinn, Chief Medical Officer & Executive Vice President
  • Todd W. Kingma, Secretary, Executive VP & General Counsel

What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo CEO Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among Perrigo's employees.

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (8.31%), Barrow Hanley Mewhinney & Strauss LLC (5.41%), London Co. of Virginia (2.39%), Dimensional Fund Advisors LP (2.30%), Sound Shore Management Inc CT (2.23%) and Coho Partners Ltd. (2.22%). Company insiders that own Perrigo stock include Geoffrey M Parker, Richard S Sorota, Rolf A Classon, Svend Andersen, Theodore R Samuels II and Todd W Kingma.
View institutional ownership trends for Perrigo

Which major investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Arrowstreet Capital Limited Partnership, Geode Capital Management LLC, Phoenix Holdings Ltd., Point72 Asset Management L.P., Deutsche Bank AG, AXA S.A., and London Co. of Virginia.
View insider buying and selling activity for Perrigo
or view top insider-selling stocks.

Which major investors are buying Perrigo stock?

PRGO stock was bought by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Coho Partners Ltd., BlackRock Inc., Millennium Management LLC, Russell Investments Group Ltd., Cooke & Bieler LP, Pendal Group Ltd, and Heartland Advisors Inc.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Richard S Sorota, Rolf A Classon, Svend Andersen, and Theodore R Samuels II.
View insider buying and selling activity for Perrigo
or or view top insider-buying stocks.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $35.79.

How much money does Perrigo make?

Perrigo has a market capitalization of $4.79 billion and generates $5.06 billion in revenue each year. The company earns $-162.60 million in net income (profit) each year or ($1.88) on an earnings per share basis.

How many employees does Perrigo have?

Perrigo employs 11,500 workers across the globe.

When was Perrigo founded?

Perrigo was founded in 1887.

What is Perrigo's official website?

The official website for Perrigo is www.perrigo.com.

Where are Perrigo's headquarters?

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at (531) 709-4000, via email at [email protected], or via fax at 269-673-9128.

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.